Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-08 Backstrom Jay T. Director Grant or award +1,447 1,447
2026-07-08 Backstrom Jay T. Director Exercise or conversion · Restricted stock units −1,447 2,894
2026-06-18 Backstrom Jay T. Director Grant or award · Restricted stock units +2,927 2,927
2026-06-18 Backstrom Jay T. Director Grant or award · Stock options (right to buy) +14,950 14,950
2025-07-08 Backstrom Jay T. Director Grant or award · Stock options (right to buy) +23,393 23,393
2025-07-08 Backstrom Jay T. Director Grant or award · Restricted stock units +4,341 4,341

Page 1 of 1 · 6 trades